TY - JOUR
T1 - Long-term bowel function after transanal minimally invasive surgery (TAMIS)
AU - Goldenshluger, Michael
AU - Gutman, Yaara
AU - Katz, Aviad
AU - Schtrechman, Gal
AU - Westrich, Gal
AU - Nissan, Aviram
AU - Segev, Lior
N1 - Publisher Copyright:
© 2020 Israel Medical Association. All rights reserved.
PY - 2020/7
Y1 - 2020/7
N2 - Background: Transanal minimally invasive surgery (TAMIS) is a single port access platform used for full thickness local excision of rectal lesions. It is an appealing alternative to a radical resection of rectum that often can cause a significant bowel dysfunction described as low anterior resection syndrome (LARS). LARS is evaluated using a validated score. Functional outcomes of patients undergoing TAMIS has not yet been evaluated using the LARS score. Objectives: To evaluate long-term bowel function in patients who underwent TAMIS. Methods: In this case series, all patients who underwent TAMIS in a single tertiary institute between 2011 and 2017 were retrospectively reviewed. We evaluated bowel function using the LARS score questionnaire through telephone interviews. Results: The study consisted of 23 patients, average age of 67 ± 6.98 year; 72% were male. The median follow-up from the time of surgery was 5 years. Six patients (26.08%) had malignant type lesions. The average height of the lesion from the anal verge was 7.4 cm. The average size of the specimen was 4 cm. The total LARS score revealed that 17 patients (73.91%) had no definitive LAR syndrome following the surgery. Four patients (17.39%) fit the description of minor LARS and only two (8.69%) presented with major LARS. Conclusions: TAMIS provides relatively good long-term functional outcomes in terms of bowel function. Further random-ized studies with larger cohorts are still needed to better evaluate the outcomes.
AB - Background: Transanal minimally invasive surgery (TAMIS) is a single port access platform used for full thickness local excision of rectal lesions. It is an appealing alternative to a radical resection of rectum that often can cause a significant bowel dysfunction described as low anterior resection syndrome (LARS). LARS is evaluated using a validated score. Functional outcomes of patients undergoing TAMIS has not yet been evaluated using the LARS score. Objectives: To evaluate long-term bowel function in patients who underwent TAMIS. Methods: In this case series, all patients who underwent TAMIS in a single tertiary institute between 2011 and 2017 were retrospectively reviewed. We evaluated bowel function using the LARS score questionnaire through telephone interviews. Results: The study consisted of 23 patients, average age of 67 ± 6.98 year; 72% were male. The median follow-up from the time of surgery was 5 years. Six patients (26.08%) had malignant type lesions. The average height of the lesion from the anal verge was 7.4 cm. The average size of the specimen was 4 cm. The total LARS score revealed that 17 patients (73.91%) had no definitive LAR syndrome following the surgery. Four patients (17.39%) fit the description of minor LARS and only two (8.69%) presented with major LARS. Conclusions: TAMIS provides relatively good long-term functional outcomes in terms of bowel function. Further random-ized studies with larger cohorts are still needed to better evaluate the outcomes.
KW - Bowel function
KW - Low anterior resection syndrome (LARS)
KW - Rectal lesion
KW - Transanal minimally invasive surgery (TAMIS)
UR - http://www.scopus.com/inward/record.url?scp=85088610879&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 33236567
AN - SCOPUS:85088610879
SN - 1565-1088
VL - 22
SP - 360
EP - 364
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 7
ER -